DCAL

March 19 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• CARBOGEN AMCIS SAS GETS GMP COMPLIANCE CERTIFICATE FOR SAINT-BEAUZIRE SITE

Source text: ID:nNSEbdqVGx

Further company coverage: DSHM.NS

(([email protected];))

** Shares of Dishman Carbogen Amcis DSHM.NS rise 2.6% to 211.4 rupees

** Contract research, manufacturing services provider approves issuance of NCDs worth up to 500 million rupees ($5.74 million) on private placement basis

** Stock trades above 100-day moving avg

** Stock down 23.7% so far this year, after a 58.2% climb in 2024

($1 = 87.0550 Indian rupees)

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

March 12 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• DISHMAN CARBOGEN AMCIS LTD - BOARD APPROVES ISSUE OF DEBENTURES AGGREGATING UP TO 500 MILLION RUPEES

Source text: ID:nBSEbnPycq

Further company coverage: DSHM.NS

(([email protected];))

March 7 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• TO CONSIDER AND APPROVE PROPOSAL OF FUND RAISING

Source text: ID:nBSE5ktT4X

Further company coverage: DSHM.NS

(([email protected];;))

Feb 12 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• DEC-QUARTER CONSOL NET PROFIT 46.3 MILLION RUPEES

• DEC-QUARTER CONSOL TOTAL INCOME FROM OPERATIONS 6.82 BILLION RUPEES

Further company coverage: DSHM.NS

(([email protected];))

Jan 10 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• DISHMAN CARBOGEN AMCIS - UNIT SUCCESSFULLY COMPLETES SWISSMEDIC INSPECTION OF VIONNAZ FACILITY

• DISHMAN CARBOGEN AMCIS LTD - VIONNAZ SITE'S GMP CERTIFICATION SUCCESSFULLY RENEWED

Source text: ID:nBSE4rn4gx

Further company coverage: DSHM.NS

(([email protected];;))

** Shares of Dishman Carbogen Amcis DSHM.NS rise 16.2% to 208 rupees

** The pharma co posted Q2 consol net PAT of 330.9 mln rupees ($3.9 mln) vs loss of 409 mln rupees a year ago; rev from ops rose 35% Y/Y

** Co says earnings were helped by higher commercial sales and rollover of some shipments which got pushed to Q2 from Q1

** More than 6.1 mln shares change hands, 13.2X its 30-day avg

** Stock up 20% YTD

($1 = 84.4025 Indian rupees)

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected]))

** Shares of India's Dishman Carbogen Amcis DSHM.NS up 8.8% after rising as much as 9.2% earlier in the day

** U.S. Food and Drug Administration has completed inspections at unit's Swiss sites; conclusions classified as "no action indicated" - drugmaker

** Stock set for its third straight week of gains, if trends hold

** YTD, DSHM has gained 6.2%

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

June 27 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• UNIT COMPLETED US FDA INSPECTION OF MANUFACTURING SITES LOCATED IN HUNZENSCHWIL AND AARAU, IN SWITZERLAND

• INSPECTIONS AT BOTH SITES WERE CONCLUDED WITH NO FORM 483 AND CLASSIFIED AS NO ACTION INDICATED

Source text for Eikon: ID:nNSE9qgPW2

Further company coverage: DSHM.NS

(([email protected];))

March 18 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• UNIT SUCCESSFULLY COMPLETED ANVISA AUDIT OF ITS FACILITY IN SHANGHAI, CHINA

• INSPECTION CONCLUDED WITH NO CRITICAL, NO MAJOR OBSERVATIONS RAISED

• GOOD MANUFACTURING PRACTICE CERTIFICATE GRANTED TO SITE BY AUTHORITY

Source text for Eikon: ID:nBSE13kGCD

Further company coverage: DSHM.NS

(([email protected];))

March 8 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• US- FDA INSPECTION AT CO'S FACILITY IN BAVLA, AHMEDABAD SUCCESSFULLY COMPLETED

• US FDA INSPECTION WAS CONCLUDED WITH FEW PROCEDURAL OBSERVATIONS

Source text for Eikon: ID:nBSE5089YT

Further company coverage: DSHM.NS

(([email protected];))

Jan 23 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• BAVLA SITE HAS BEEN DECLARED GMP COMPLIANT BY JAPANESE PHARMACEUTICALS AND MEDICAL DEVICES AGENCY

Further company coverage: DSHM.NS

(([email protected];))

Sept 21 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• BAVLA SITE WAS SUCCESSFULLY JOINTLY INSPECTED BY EDQM AND ITALIAN MEDICINES AGENCY

• FINAL REPORT IS AWAITED

Source text for Eikon: ID:nBSE6pgbQp

Further company coverage: DSHM.NS

(([email protected];))

Aug 9 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• JUNE-QUARTER CONSOL NET PAT 170 MILLION RUPEES VERSUS 40.1 MILLION RUPEES

• JUNE-QUARTER CONSOL TOTAL INCOME 7.3 BILLION RUPEES VERSUS 5.46 BILLION RUPEES

Source text for Eikon: ID:nBSE4Cfy6t

Further company coverage: DSHM.NS

(([email protected];;))

** Shares of Dishman Carbogen Amcis Ltd DSHM.NS tumble as much as 12.16% to a near three-month low of 114.50 rupees

** Supplier of specialty chemicals and active pharmaceutical ingredients reports widened net loss after tax in March quarter to 707.2 mln rupees, compared to 446.2 mln rupees Y/Y

** Loss widened due to fall in lower core profit margin in Dutch business due to high raw material costs; higher power and fuel costs also weighed on earnings: DSHM

** Trading volume is 1.97 mln shares as of 11:17 a.m. IST, 2.4x the 30-day avg - Refinitiv data

($1 = 81.7800 Indian rupees)

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))

May 23 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS:

• INDIA'S DISHMAN CARBOGEN AMCIS LTD MARCH-QUARTER CONSOL NET LOSS AFTER TAX 707.2 MILLION RUPEES VERSUS LOSS 446.2 MILLION RUPEES

• DISHMAN CARBOGEN AMCIS LTD MARCH-QUARTER CONSOL TOTAL INCOME FROM OPERATIONS 6.19 BILLION RUPEES VERSUS 5.69 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: DSHM.NS

(([email protected];))